name | dxc |
sex | female
|
age | 60 岁 |
hospital number | 17008489 |
height | 170 cm |
weight | 70 kg |
BSA | 1.85 m2 |
APACHEⅡ | 分 |
Infection source | abdominal
|
date | 2017/3/17 年/月/日 |
Sequential Organ Failure Assessment | 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
|
age>=60 | yes
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | no
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | no
|
no
|
|
no
|
|
no
|
|
no
|
|
no
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
头孢哌酮舒巴坦2.0ivgtt q8h、泰能0.5ivgtt q6h |
|
vasoactive agent | norepinephrine
/vasopressin
|
4140 min |
|
0 min |
|
4140 min |
Temperature | 37 ℃ |
Heart Rate | 113 次/分 |
Breath | 15 次/分 |
Systolic pressure (SP) | 131 mmHg |
Diastolic pressure | 46 mmHg |
mean arterial pressure | 63 mmHg |
Pcv-aCO2 | -2 mmHg |
DO2 | 971.66 |
VO2 | 229.52 |
Ca-vO2 | 25.82 |
pH value | 7.29 |
PaO2 | 56 mmHg |
PaCO2 | 44 mmHg |
BE | -5.7 mmol/L(±2.3mmol/L) |
SaO2 | 91.3 % |
Blood lactic acid concentration, LAC | 11.2 mmol/L |
Oxygenation index (PaO2/FiO2) | 93.33 mmHg |
pH value | 7.31 |
PcvO2 | 36 mmHg |
PcvCO2 | 42 mmHg |
BE | -5.3 mmol/L |
ScvO2 | 69.7 % |
Volume of input | 100 ml |
Volume of output | 150 ml |
Volume of urine | 0 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 0.8 μg/Kg/min |
dopamine | no
|
Dopamine Dosage | μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
Pituitrin
|
CVP | 3 mmHg |
cardiac output | 8.91 L/min |
cardiac index | 4.65 L/min/m2 |
stroke volume | 85 ml |
Stroke Index | 33 ml/m2 |
ITBVI | 785 ml/m2 |
GEDVI | 628 ml/m2 |
EVLWI | 7 ml/kg |
PVPI | 1.6 |
SVRI | 939 DSm2/cm5 |
CFI | 8 |
GEF | 30 % |
SVV | 13 % |
PPV | 11 % |
dPmax | 1032 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 2 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 22.9 mm |
IVC(expiratory phase) | 18.6 mm |
respiratory variations of inferior vena cavae diameter | 20.72 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 34.5 ℃ |
Heart Rate | 79 次/分 |
Breath | 19 次/分 |
Systolic Pressure | 114 mmHg |
Diastolic Pressure | 56 mmHg |
Mean Arterial Pressure | 61 mmHg |
Pcv-aCO2 | 7 mmHg |
DO2 | 981.45 |
VO2 | 261.11 |
Ca-vO2 | 29.44 |
PH value | 7.34 |
PaO2 | 66 mmHg |
PaCO2 | 37 mmHg |
BE | -1.5 mmol/L |
SaO2 | 92.3 % |
Blood Lactic Acid Concentration | 8.1 mmol/L |
Oxygenation index (PaO2/FiO2) | 110 mmHg |
PH value | 7.36 |
PcvO2 | 32 mmHg |
PcvCO2 | 44 mmHg |
BE | -1.3 mmol/L |
ScvO2 | 67.7 % |
Volume of input | 1500 ml |
Volume of output | 1100 ml |
Volume of urine | 80 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 5.12 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | 4.32 U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 14 mmHg |
cardiac output | 8.9 L/min |
cardiac index | 4.64 L/min/m2 |
stroke volume | 117 ml |
Stroke Index | 61 ml/m2 |
ITBVI | 978 ml/m2 |
GEDVI | 782 ml/m2 |
EVLWI | 9 ml/kg |
PVPI | 1.7 |
SVRI | 939 DSm2/cm5 |
CFI | 6.4 |
GEF | 61 % |
SVV | 15 % |
PPV | 8 % |
dPmax | 2886 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 3 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 19.8 mm |
IVC(expiratory phase) | 18.2 mm |
Respiratory variations of inferior vena cavae diameter | 8.42 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 35 ℃ |
Heart Rate | 82 次/分 |
Breath | 19 次/分 |
Systolic Pressure | 134 mmHg |
Diastolic Pressure | 50 mmHg |
Mean Arterial Pressure | 76 mmHg |
Pcv-aCO2 | -2.00 mmHg |
DO2 | 967.79 |
VO2 | 278.00 |
Ca-vO2 | 31.24 |
PH value | 7.39 |
PaO2 | 67 mmHg |
PaCO2 | 38 mmHg |
BE | -1.7 mmol/L |
SaO2 | 90.00 % |
Blood Lactic Acid Concentration | 8.2 mmol/L |
Oxygenation index (PaO2/FiO2) | 111.67 mmHg |
PH value | 7.4 |
PcvO2 | 64 mmHg |
PcvCO2 | 36 mmHg |
BE | -2.5 mmol/L |
ScvO2 | 64.10 % |
Volume of input | 4416 ml |
Volume of output | 2913 ml |
Volume of urine | 110 ml |
Ultrafiltration Volume | 1200 ml |
Norepinephrine Dosage | 28 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | 8.64 U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 13 mmHg |
cardiac output | 8.9 L/min |
cardiac index | 4.64 L/min/m2 |
stroke volume | 117 ml |
Stroke Index | 61 ml/m2 |
ITBVI | 978 ml/m2 |
GEDVI | 782 ml/m2 |
EVLWI | 9 ml/kg |
PVPI | 1.7 |
SVRI | 939 DSm2/cm5 |
CFI | 6.4 |
GEF | 31 % |
SVV | 15 % |
PPV | 8 % |
dPmax | 2886 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 3 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 2.12 mm |
IVC(expiratory phase) | 1.88 mm |
Respiratory variations of inferior vena cavae diameter | 12 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 35.2 ℃ |
Heart Rate | 83 次/分 |
Breath | 15 次/分 |
Systolic Pressure | 127 mmHg |
Diastolic Pressure | 36 mmHg |
Mean Arterial Pressure | 58 mmHg |
Pcv-aCO2 | 3.00 mmHg |
DO2 | 864.32 |
VO2 | 317.22 |
Ca-vO2 | 43.43 |
PH value | 7.38 |
PaO2 | 84 mmHg |
PaCO2 | 41 mmHg |
BE | -1.3 mmol/L |
SaO2 | 97.70 % |
Blood Lactic Acid Concentration | 7.2 mmol/L |
Oxygenation index (PaO2/FiO2) | 140.00 mmHg |
PH value | 7.36 |
PcvO2 | 32 mmHg |
PcvCO2 | 44 mmHg |
BE | -1.3 mmol/L |
ScvO2 | 61.00 % |
Volume of input | 6319 ml |
Volume of output | 5893 ml |
Volume of urine | 110 ml |
Ultrafiltration Volume | 1950 ml |
Norepinephrine Dosage | 133.42 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | 17.28 U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 11 mmHg |
cardiac output | 7.33 L/min |
cardiac index | 3.83 L/min/m2 |
stroke volume | 114 ml |
Stroke Index | 59 ml/m2 |
ITBVI | 747 ml/m2 |
GEDVI | 598 ml/m2 |
EVLWI | 7 ml/kg |
PVPI | 1.8 |
SVRI | 881 DSm2/cm5 |
CFI | 6.9 |
GEF | 34 % |
SVV | 15 % |
PPV | 7 % |
dPmax | 3187 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 4 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 2.31 mm |
IVC(expiratory phase) | 2.03 mm |
Respiratory variations of inferior vena cavae diameter | 12.90 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.6 ℃ |
Heart Rate | 75 次/分 |
Breath | 25 次/分 |
Systolic Pressure | 133 mmHg |
Diastolic Pressure | 52 mmHg |
Mean Arterial Pressure | 78 mmHg |
Pcv-aCO2 | 4 mmHg |
DO2 | 879.63 |
VO2 | 270.50 |
Ca-vO2 | 34.41 |
PH value | 7.52 |
PaO2 | 69 mmHg |
PaCO2 | 31 mmHg |
BE | 1.7 mmol/L |
SaO2 | 97.7 % |
Blood Lactic Acid Concentration | 6.5 mmol/L |
Oxygenation index (PaO2/FiO2) | 115.00 mmHg |
PH value | 7.49 |
PcvO2 | 28 mmHg |
PcvCO2 | 35 mmHg |
BE | 2.4 mmol/L |
ScvO2 | 67.60 % |
Volume of input | 10200 ml |
Volume of output | 11162 ml |
Volume of urine | 124 ml |
Ultrafiltration Volume | 7695 ml |
Norepinephrine Dosage | 273.02 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | 34.56 U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 14 mmHg |
cardiac output | 7.89 L/min |
cardiac index | 4.12 L/min/m2 |
stroke volume | 122 ml |
Stroke Index | 63 ml/m2 |
ITBVI | 1019 ml/m2 |
GEDVI | 875 ml/m2 |
EVLWI | 9 ml/kg |
PVPI | 1.6 |
SVRI | 1705 DSm2/cm5 |
CFI | 5.5 |
GEF | 40 % |
SVV | 13 % |
PPV | 11 % |
dPmax | 2187 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 4 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 25.4 mm |
IVC(expiratory phase) | 22.9 mm |
Respiratory variations of inferior vena cavae diameter | 10.35 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.3 ℃ |
Heart Rate | 97 次/分 |
Breath | 12 次/分 |
Systolic Pressure | 139 mmHg |
Diastolic Pressure | 65 mmHg |
Mean Arterial Pressure | 90 mmHg |
Pcv-aCO2 | 6 mmHg |
DO2 | 698.06 |
VO2 | 202.46 |
Ca-vO2 | 30.59 |
PH value | 7.48 |
PaO2 | 79 mmHg |
PaCO2 | 34 mmHg |
BE | 1.1 mmol/L |
SaO2 | 97.70 % |
Blood Lactic Acid Concentration | 5.8 mmol/L |
Oxygenation index (PaO2/FiO2) | 131.67 mmHg |
PH value | 7.46 |
PcvO2 | 31 mmHg |
PcvCO2 | 40 mmHg |
BE | 3 mmol/L |
ScvO2 | 69.30 % |
Volume of input | 14421 ml |
Volume of output | 16570 ml |
Volume of urine | 182 ml |
Ultrafiltration Volume | 8095 ml |
Norepinephrine Dosage | 320.52 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | 51.84 U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 14 mmHg |
cardiac output | 6.65 L/min |
cardiac index | 3.47 L/min/m2 |
stroke volume | 7 ml |
Stroke Index | 51 ml/m2 |
ITBVI | 837 ml/m2 |
GEDVI | 669 ml/m2 |
EVLWI | 6 ml/kg |
PVPI | 1.3 |
SVRI | 1820 DSm2/cm5 |
CFI | 5.6 |
GEF | 34.00 % |
SVV | 6.00 % |
PPV | 5 % |
dPmax | 1378 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 4 分 |
B+ Zone | 区 |
IVC(expiratory phase) | 24.6 mm |
Respiratory variations of inferior vena cavae diameter | 21.2 % |
IVC(inspiratory phase) | 14.85 mm |
mm |
|
mm |
|
mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 1230 pg/ml |
cTNI | 0.318 ng/ml |
Creatine kinase isoenzyme, CKMB | 43.7 U/L |
Creatinine | 163 umol/L |
Urea nitrogen | 7.4 mmol/l |
MDRD | 37.62 ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 21.1 X10*9/L |
neutrophilic granulocyte percentage | 87.8 % |
Hb | g/L |
CRP | 19.3 mg/L |
Procalcitonin, PCT | 2.1 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 20 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 1240 pg/ml |
cTNI | 0.455 ng/ml |
Creatine kinase isoenzyme, CKMB | 46.6 U/L |
Creatinine | 134 umol/L |
Urea nitrogen | 5 mmol/l |
MDRD | 47.163 ml/min/1.73m2 |
WBC | 22.2 X10*9/L |
neutrophilic granulocyte percentage | 96.1 % |
Hb | g/L |
CRP | 57.2 mg/L |
Procalcitonin, PCT | 3.05 ng/ml |
Sequential Organ Failure Assessment | 20 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 984 pg/ml |
cTNI | 0.829 ng/ml |
Creatine kinase isoenzyme, CKMB | 34.5 U/L |
Creatinine | 76 umol/L |
Urea nitrogen | 5.4 mmol/L |
MDRD | 90.745 ml/min/1.73m2 |
WBC | 15.3 X10*9/L |
neutrophilic granulocyte percentage | 85.7 % |
Hb | g/L |
CRP | 56.7 mg/L |
Procalcitonin, PCT | 2.02 ng/ml |
Sequential Organ Failure Assessment | 20 分 |
Transfusion of Red Cells | yes
|
Transfusion of Red Cells | 3 U |
Plasma infusion | yes
|
Plasma infusion | 1500 ml |
platelet transfusion | yes
|
platelet transfusion | 10 U |
APACHEⅡ | 21 分 |
Complication | no
|
prognosis | die
|
28-day mortality | yes
|
survival time(day) | 7 天 |
death time | 2017/3/21 yyyy/mm/dd |
diagnosis of death | 感染性休克、腹腔闭合性损伤、失血性休克 |
length of stay | 7 天 |
duration in ICU | 7 天 |
duration of mechanical ventilation | 168 小时 |
ICU expenses | 166984.22 元 |
Continuous Renal Replacement Therapy | yes
|
Continuous Renal Replacement Therapy | 120 小时 |